Agios Pharmaceuticals | AGIO - Bénéfice Avant Impôts





Bénéfice Avant Impôts Changement Date
AbbVie USD 7.61B 2.04B 2026-06
Agios Pharmaceuticals USD -99.11M 9.94M 2026-03
Alnylam Pharmaceuticals USD 177.81M 43.85M 2026-06
Amgen USD 2.08B 570M 2026-03
Arrowhead Research USD -178.9M 41.34M 2026-06
Astellas Pharma JPY 186.51B 138.49B 2026-06
AstraZeneca USD 4.81B 894M 2026-06
Bayer EUR 321M 2.67B 2026-06
Biogen USD 647.3M 269.6M 2026-06
BioMarin Pharmaceutical USD 141.2M 168.36M 2026-03
Bristol-Myers Squibb USD 4.99B 1.75B 2026-06
Daiichi Sankyo JPY -6.52B 113.25B 2026-03
Eli Lilly USD 8.85B 583.8M 2026-03
Exelixis USD 262.68M 5.01M 2026-06
Gilead Sciences USD -7.53B 10.11B 2026-06
GlaxoSmithKline GBP 2.68B 532M 2026-06
Incyte USD 751.51M 407.91M 2026-06
Ionis Pharmaceuticals USD -114M 21M 2026-06
Merck USD -3.53B 6.95B 2026-03
Moderna USD -1.33B 535M 2026-03
Nektar Therapeutics USD -43.09M 8.39M 2026-03
Novartis USD 4.27B 430M 2026-06
Novartis USD 3.84B 1.33B 2026-03
Pfizer USD -653M 5.84B 2026-06
Puma Biotechnology USD 20.61M 24.76M 2024-09
Regeneron Pharmaceuticals USD 1.53B 696.6M 2026-06
Roche Holding CHF 11.17B 6.38B 2026-06
Sarepta Therapeutics USD -1.75M 344.92M 2026-06
Vertex Pharmaceuticals USD 1.39B 138.9M 2026-06